The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 13, 2016

Filed:

Nov. 11, 2013
Applicant:

Alexza Pharmaceuticals, Inc., Mountain View, CA (US);

Inventors:

Ron L. Hale, Sandia Park, NM (US);

Craig C. Hodges, Walnut Creek, CA (US);

Peter M. Lloyd, Walnut Creek, CA (US);

Daniel Mufson, Napa, CA (US);

Daniel D. Rogers, Oakland, CA (US);

Soonho Song, Seoul, KR;

Martin J. Wensley, Los Gatos, CA (US);

Daniel J. Myers, Mountain View, CA (US);

Jeffrey A. McKinney, Lafayette, CA (US);

Reynaldo J. Quintana, Menlo Park, CA (US);

Joshua D. Rabinowitz, Princeton, NJ (US);

Assignee:

ALEXZA PHARMACEUTICAL, INC., Mountain View, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61M 15/00 (2006.01); B05B 7/16 (2006.01); B05B 17/04 (2006.01); A61M 11/02 (2006.01); A61K 31/235 (2006.01); A61K 31/4468 (2006.01); A61M 11/00 (2006.01); A61M 16/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 9/007 (2013.01); A61K 9/0073 (2013.01); A61K 31/235 (2013.01); A61K 31/4468 (2013.01); A61M 11/001 (2014.02); A61M 11/02 (2013.01); A61M 15/00 (2013.01); A61M 15/0028 (2013.01); B05B 7/1686 (2013.01); B05B 17/04 (2013.01); A61M 2016/0039 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/368 (2013.01); A61M 2205/3653 (2013.01); A61M 2205/50 (2013.01);
Abstract

The present application relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition of a drug to form a vapor, wherein the coated composition is in the form of a film less than 10μ thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method involves: (a) heating a substrate coated with a composition of a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.1 mg; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.


Find Patent Forward Citations

Loading…